Hadassah

Hadassah Transplant Center Reopens, Completes Complex Liver Transplant

Tuesday, May 5 2015

Dr. Hadar Merhav

A liver transplant operation, which lasted nine hours, was executed successfully at Hadassah Medical Organization (HMO) last week. This is the first liver transplant procedure performed since the transplant unit resumed full activity.

The patient, a 56-year-old male who suffers from a serious disease, had been waiting for the past two years to find a suitable liver. He is in stable condition.

The team at the HMO transplant unit was led by Dr. Hadar Merhav and assisted by Prof. Gidi Zamir and Dr. Ram Elazari. Dr. Merhav said of the procedure: "The patient suffered from advanced stage liver disease and the transplant was complex. I’m very pleased that the teamwork went smoothly, without any unpredictable complications and that the new liver is functioning.”

Hadassah’s transplant unit recently returned to its normal activity, approved by Prof. Rafi Beyar, Chairman of the steering committee of the National Transplant Center.

Hadassah is centralizing transplants in a single center, which will take care of patients requiring transplants of any kind. This new clinic will allow Hadassah to concentrate all of the experts under one roof, including social workers, nephrologists, surgeons, and cardiologists. The center will take advantage of the facilities of the new advanced operating rooms that are scheduled to be ready at HMO over the next few months.

Interim Director General of Hadassah, Prof. Tamar Peretz, emphasized that around 30 transplants a year were completed at HMO over the past several years and the results passed every international standard. "Hadassah is committed to the continuation of the transplant center as an essential public service, a symbol of excellency and a magnet for academic research," Prof. Peretz said.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
alt_text

Friday, Aug 2 2019

Eloxx Pharmaceuticals Announces New Drug Application for Clinical Trial in Cystic Fibrosis Patients

Professor Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Organization, will serve as the Global Lead Investigator for this clinical trial.

READ MORE ›
alt_text

Wednesday, Jul 31 2019

Skin Cancer Treatment Enhanced in New Center for Dermatologic Surgery

Thanks to a donation by the Israeli businessman and philanthropist Morris Kahn, a major supporter of the Israeli moon spacecraft “Beresheet,” Hadassah Hospital Ein Kerem has just opened the new Center for Dermatologic Surgery, which offers Mohs surgery for patients with common types of skin cancer.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More